Skandinaviska Enskilda Banken Ab (Publ) Chimerix Inc Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $19.9 Billion
- Q1 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Chimerix Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,300 shares of CMRX stock, worth $11,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,300Holding current value
$11,101% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
84Shares Held
42.6MCall Options Held
243KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA8.8MShares$75.2 Million0.5% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$32.2 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$31.2 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.78MShares$23.8 Million1.31% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$21.8 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...